Kedrion presented at plasma fractionation workshop in Saudi Arabia
An opportunity to share our knowledge and long-standing experience in this industry
Kedrion awarded national tender for Portuguese plasma manufacturing
First shipments of plasma from Porto and Lisbon were received in the beginning of February
Kedrion Biopharma joins Rare Disease Day
Raising awareness and generating change for the people living with a rare disease
The Fifth John Gorman Lectureship at the BIRTH 2022 Congress
These Conferences in Transfusion Medicine are made possible thanks to the unconditional support of Kedrion Biopharma
Kedrion strengthens its network of plasma collection centers
Five centers acquired in the Czech Republic
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Announced appointment of Ugo Di Francesco as CEO
Kedrion alongside the World Hepatitis Alliance
The company is proud to support WHA’s initiative aimed at preventing mother-to-child transmission (PMTCT) of Hepatitis B
Kedrion Biopharma Recognized for innovation in Treating Rare Disease
Prestigious recognition presented for the first ever treatment for Plasminogen Deficiency
Kedrion and IPOPI: the journey continues at the 2022 IPIC
The Primary Immunodeficiencies International Congress took place during World PI Week
World Hemophilia Day: Kedrion’s commitment
Guaranteeing equitable access to treatment is the central theme of the 2022 edition
